E-Flask
↗Seongnam, South Korea
E-Flask is a South Korean biotechnology company established as an NRDO (No Research Development Only) entity. The company focuses on developing 'First-in-Class' therapeutics aimed at improving the quality of life (QoL) for aging populations, specifically targeting neurodegenerative, musculoskeletal, and sensory organ diseases.
Founded by former executives from Daewoong Pharmaceutical and backed by Song-Am Sa (the holding company of Shinpoong Pharmaceutical), E-Flask utilizes an open innovation model. They partner with AI-driven drug discovery firms and academic institutions to rapidly advance their pipeline from candidate selection through clinical proof-of-concept.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:CNS and Aging-related Therapeutics
SIZE & FINANCIALS
Employees:1-50
Revenue:Pre-revenue
Founded:2020
Ownership:subsidiary
Status:operating
FUNDING
Stage:Series A
Total Raised:$13M
Investors:Song-Am Sa, Stonebridge Ventures, KDB Bank, Shinhan Capital
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1 (EF-101)
Modalities:Small molecule, Peptide
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Song-Am Sa (Shinpoong Pharmaceutical Group)
Key Partnerships:Daewoong Pharmaceutical (Strategic R&D), Baobab AiBio (AI Drug Discovery), Deergen (AI Target Discovery), Simplex (AI-based CNS drug development), C-Biomex (Peptide therapeutics)
COMPETITION
Position:Emerging
Competitors:ABL Bio, AriBio, Genuv, Neuracle Science
LEADERSHIP
Key Executives:
Kyung-goo Kang - CEO
Chae-young Shin - Head of Research Center
Scientific Founders:Kyung-goo Kang
LINKS
Website:eflask.co.kr
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with E-Flask. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.